Drug intelligence / Profile preview

Suxin Tongqiao Granules

Development stage: Unknown
Lead developer: Lianyungang Kanion
Modality: Small Molecules
Administration: Oral

Overview

Suxin Tongqiao Granules is an innovative Traditional Chinese Medicine (TCM) candidate developed by Jiangsu Kanion Pharmaceutical for the treatment of persistent allergic rhinitis. Classified as a Category 1.1 new drug in China, it is formulated to alleviate symptoms such as nasal congestion, rhinorrhea, and sneezing by addressing the underlying inflammatory and allergic processes. The drug is believed to function by modulating the immune response and inhibiting the release of inflammatory mediators associated with Type I hypersensitivity. Clinical evaluation in Phase 2 and Phase 3 trials has focused on its efficacy in reducing the Total Nasal Symptom Score (TNSS) and improving patient quality of life compared to standard antihistamine or corticosteroid therapies.

Brand names: Suxin Tongqiao Granules
Other names: Suxin Tongqiao Keli宿辛通窍颗粒

Beyond the preview

Go deeper on Suxin Tongqiao Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suxin Tongqiao Granules.

Explore the full profile